-+ 0.00%
-+ 0.00%
-+ 0.00%

CREATIVE MEDICAL TECHNOLOGY HOLDINGS SECURES FDA CLEARANCE FOR EXPANDED DOSE ESCALATION IN THE CLINICAL TRIAL OF CELZ-201-DDT FOR CHRONIC LOWER BACK PAIN

Reuters·03/20/2025 11:50:00

Please log in to view news